4//SEC Filing
Pearce Tillman 4
Accession 0001181431-13-018645
CIK 0001183765other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 7:08 PM ET
Size
5.4 KB
Accession
0001181431-13-018645
Insider Transaction Report
Form 4
Pearce Tillman
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-03-13+140,000→ 140,000 totalExercise: $5.09Exp: 2023-03-13→ Common Stock (140,000 underlying)
Footnotes (2)
- [F1]The stock option was granted pursuant to the Threshold Pharmaceuticals, Inc. 2004 Amended and Restated Equity Incentive Plan.
- [F2]The option vests as to 1/48th of the shares on a monthly basis such that the options are 100% vested as of March 13, 2017.
Documents
Issuer
THRESHOLD PHARMACEUTICALS INC
CIK 0001183765
Entity typeother
Related Parties
1- filerCIK 0001542778
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 7:08 PM ET
- Size
- 5.4 KB